Published in Mol Cancer on July 21, 2011
Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis (2013) 2.02
A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer (2014) 1.26
Advances in epigenetic biomarker research in colorectal cancer. World J Gastroenterol (2014) 1.02
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene (2012) 1.00
Toward a comprehensive and systematic methylome signature in colorectal cancers. Epigenetics (2013) 1.00
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics (2012) 0.98
Genetic and epigenetic traits as biomarkers in colorectal cancer. Int J Mol Sci (2011) 0.90
Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity. Oncol Rep (2014) 0.88
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology (2015) 0.87
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer (2014) 0.86
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin Transl Gastroenterol (2012) 0.85
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma. Epigenetics (2013) 0.83
DNA Methylation and Colorectal Cancer. Curr Colorectal Cancer Rep (2014) 0.82
Fecal molecular markers for colorectal cancer screening. Gastroenterol Res Pract (2011) 0.82
CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer. Oncotarget (2015) 0.80
Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer. Oncol Lett (2014) 0.80
Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules. J Thorac Dis (2015) 0.79
Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation. Mol Pharmacol (2015) 0.78
Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma. PLoS One (2013) 0.77
Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer. Oncotarget (2016) 0.77
Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia. BMC Cancer (2016) 0.77
Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches. Bioorg Med Chem Lett (2014) 0.76
Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples. PLoS One (2013) 0.76
Stromal Modulators of TGF-β in Cancer. J Clin Med (2017) 0.76
Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ. BMC Cancer (2016) 0.75
Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method. Oncol Lett (2017) 0.75
Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. Dis Markers (2015) 0.75
Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC. Oncotarget (2017) 0.75
Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication. Med Sci Monit (2017) 0.75
UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response. Oncotarget (2016) 0.75
Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. World J Gastrointest Oncol (2017) 0.75
Epigenetics in diagnosis of colorectal cancer. Mol Biol Res Commun (2016) 0.75
Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing. Oncogene (2016) 0.75
The human genome browser at UCSC. Genome Res (2002) 168.23
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A (1977) 13.87
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res (2005) 6.49
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet (2002) 5.38
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature (1991) 4.77
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst (2005) 3.73
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res (2004) 3.23
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol (2008) 3.16
Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol (1999) 2.89
Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res (2006) 2.70
DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem (2007) 2.65
Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem (2009) 2.57
DNA methylation markers in colorectal cancer. Cancer Metastasis Rev (2010) 2.40
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med (2006) 2.16
Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res (1999) 2.04
CpG island methylation in colorectal adenomas. Am J Pathol (2001) 1.88
CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol (2002) 1.83
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol (2002) 1.68
Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev (2007) 1.67
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer (2011) 1.65
Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia (2005) 1.63
Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci (2010) 1.51
ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol (2006) 1.48
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. PLoS One (2008) 1.46
Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One (2010) 1.40
Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia (2005) 1.33
Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res (2007) 1.20
Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci (2007) 1.19
DNA methylation in colorectal cancer--impact on screening and therapy monitoring modalities? Dis Markers (2007) 1.17
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol (2008) 1.16
Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol (2011) 1.16
Evidence for colorectal cancer screening. Best Pract Res Clin Gastroenterol (2010) 1.14
Genome signatures of colon carcinoma cell lines. Cancer Genet Cytogenet (2004) 1.13
Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer (1991) 1.12
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med (2008) 1.11
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene (2011) 1.06
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One (2009) 1.06
Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet (2010) 1.06
DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors. Gastroenterology (2007) 1.03
DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum (2007) 1.02
SFRP2 methylation in fecal DNA--a marker for colorectal polyps. Int J Colorectal Dis (2007) 1.02
Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepatogastroenterology (2010) 1.02
The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene (2007) 1.00
Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin Chem (2009) 0.98
Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer. Clin Invest Med (2011) 0.92
Performance improvements of stool-based screening tests. Best Pract Res Clin Gastroenterol (2010) 0.89
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78
[In Process Citation]. Tidsskr Nor Laegeforen (2015) 6.35
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69
Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 5.05
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation (2007) 4.10
[More harm than benefit - how much should the patients know?]. Tidsskr Nor Laegeforen (2017) 3.82
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol (2008) 3.16
Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics (2004) 3.02
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. Cancer Res (2006) 2.82
PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat Cell Biol (2010) 2.33
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol (2009) 2.08
[What should non-inferiority studies be called in Norwegian?]. Tidsskr Nor Laegeforen (2014) 1.98
The capsule and colorectal-cancer screening--the crux of the matter. N Engl J Med (2009) 1.95
Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer (2004) 1.72
The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer (2006) 1.67
Autophagy in tumour suppression and promotion. Mol Oncol (2009) 1.64
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut (2012) 1.63
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol (2012) 1.63
Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin Cancer Res (2010) 1.62
The sudden infant death syndrome gene: does it exist? Pediatrics (2004) 1.57
Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin. EMBO Rep (2012) 1.57
Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial. BMJ (2008) 1.57
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
Colonoscopy as a triage screening test. N Engl J Med (2012) 1.55
Screening for colorectal cancer. Acta Oncol (2005) 1.53
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res (2005) 1.52
ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol (2006) 1.48
Coffee consumption and circulating B-vitamins in healthy middle-aged men and women. Clin Chem (2008) 1.48
Which tool is best for colorectal cancer screening? BMJ (2010) 1.47
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer (2007) 1.44
[Implementation of guidelines for PSA testing in general practice]. Tidsskr Nor Laegeforen (2014) 1.39
[Colorectal cancer--a disease one doesn't talk about]. Tidsskr Nor Laegeforen (2007) 1.39
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome. Int J Cancer (2011) 1.39
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia (2012) 1.39
Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. J Clin Oncol (2007) 1.38
Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. J Clin Oncol (2003) 1.36
Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol (2013) 1.35
Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia (2005) 1.33
Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene (2002) 1.32
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer (2008) 1.31
Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol (2006) 1.28
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One (2010) 1.26
New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res (2002) 1.25
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer (2007) 1.23
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer (2007) 1.22
TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. Epigenetics (2011) 1.20
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet (2013) 1.19
Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum (2012) 1.18
Improvement in caecal intubation rate and pain reduction by using 3-dimensional magnetic imaging for unsedated colonoscopy: a randomized trial of patients referred for colonoscopy. Scand J Gastroenterol (2007) 1.18
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer. Genes Chromosomes Cancer (2011) 1.17
Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev (2013) 1.17
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A. Neoplasia (2008) 1.17
UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy (2010) 1.16
The Norwegian Gastronet project: Continuous quality improvement of colonoscopy in 14 Norwegian centres. Scand J Gastroenterol (2006) 1.16
Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol (2007) 1.15